| Financial Year |
March 31 2023 |
| Monetary Funds |
2,896,038,855.07 |
| Held-for-trading Financial Assets |
40,017,999.40 |
| Notes Receivable |
11,182,870.82 |
| Accounts Receivable |
461,622,292.28 |
| Advances to Suppliers |
19,346,046.26 |
| Other Receivables |
53,553,862.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,350,439,369.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
87,912,326.19 |
| Other Current Assets |
135,425,985.39 |
| Total Current Assets |
5,055,539,606.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
49,045,191.41 |
| Fixed Assetes |
364,861,524.26 |
| Under-construction Projects |
286,090,595.83 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,150,012,258.79 |
| R&D expenses |
690,672,394.04 |
| Goodwill |
494,132,199.41 |
| Long-Term Deferred and Prepaid Expenses |
7,233,125.18 |
| Deferred Income Tax Assets |
525,484,760.64 |
| Other Non-Current Assets |
211,208,266.09 |
| Sub-Total of Non-Current Assets |
4,072,576,323.54 |
| Total Assets |
9,128,115,930.16 |
| Short-Term Loans |
519,850,389.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,440,458.46 |
| Accounts Payable |
143,096,534.68 |
| Accounts Received In Advance |
3,707,055.54 |
| Employee Compensation Payable |
94,016,200.89 |
| Taxes Payable |
24,832,157.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
252,580,455.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
120,401,302.62 |
| Other Current Liabilities |
749,040.44 |
| Sub-Total of Current Liabilities |
1,169,435,443.76 |
| Long-term Loans |
138,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
15,497,880.79 |
| Deferred Income Tax Liabilities |
72,939,169.74 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
293,659,189.80 |
| Total Liabilities |
1,463,094,633.56 |
| Paid-In Capital(Or Share Stock) |
458,074,341.00 |
| Capital Surplus |
1,829,526,355.51 |
| Surplus Reserve |
229,281,035.00 |
| LESS:Treasury Stock |
353,232,776.84 |
| Undistributed Profits |
5,554,339,423.40 |
| Minority Stockholder's Interest |
5,594.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,665,015,701.70 |
| Owner's Equity（Stockholder's Equity） |
7,665,021,296.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,128,115,930.16 |
